Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I/II clinical trial
Nitesh V. Patel, Tamika Wong, Sherese Fralin, Mona Li, Amy McKeown, Deborah Gruber, Randy S. D’Amico, Athos Patsalides, Apostolos John Tsiouris, Dimitre G. Stefanov, Oscar Falcón Flores, Avraham Zlochower, Christopher G. Filippi, Rafael Ortiz, David J. Langer, John A. Boockvar
Topics & Concepts
BevacizumabMedicineInternal medicineConfidence intervalIsocitrate dehydrogenasePhases of clinical researchGastroenterologySurgeryUrologyOncologyClinical trialChemotherapyEnzymeBiochemistryChemistryGlioma Diagnosis and TreatmentBrain Metastases and TreatmentAngiogenesis and VEGF in Cancer